Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: GSK to pay up to $3.3 billion for Affinivax; Senate bill tries to avoid another Aduhelm controversy

    by Ed Silverman May 31, 2022 1 minute
    Source: Alex Hogan/STAT

    Good morning, everyone, and welcome to another working week. We hope the weekend respite, which was longer on this side of the pond,

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Ozempic And An Eye Condition, A Failed Roche Cancer Drug Trial, And More
    A study reported for the first time a potential link between Novo Nordisk's GLP-1 drugs and an eye condition that can cause vision loss.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FTC Probing Teva Patents, A Moderna Flu Vaccine Contract, And More
    The FTC is investigating Teva Pharmaceuticals after it refused to remove about two dozen patents for asthma and COPD inhalers from a federal registry.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Merck Pneumococcal Shot, Kansas Suing Pfizer, And More
    In today's Pharmalittle roundup, we're reading about a Merck pneumococcal shot, Kansas suing Pfizer, and more.

    Related Books & Audiobooks